Thyrocare Technologies Ltd
NSE:THYROCARE
Relative Value
The Relative Value of one
THYROCARE
stock under the Base Case scenario is
308.28
INR.
Compared to the current market price of 358.85 INR,
Thyrocare Technologies Ltd
is
Overvalued by 14%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
THYROCARE Competitors Multiples
Thyrocare Technologies Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Thyrocare Technologies Ltd
NSE:THYROCARE
|
57.1B INR | 7.2 | 41.2 | 23 | 29.7 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
96.8B USD | 0.2 | 54.7 | 14 | 14 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
67.3B EUR | 0.3 | 13.1 | 7.7 | 9.8 | |
| US |
|
Cigna Corp
NYSE:CI
|
70.4B USD | 0.3 | 11.8 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
26.5B EUR | 1.2 | 20.9 | 9.8 | 14.6 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.1B EUR | 1.2 | 23.6 | 9.1 | 16.8 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
22B USD | 2 | 22.3 | 12.3 | 16.7 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.7B USD | 1.6 | 24.7 | 12 | 17.3 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11B EUR | 0.6 | 11.4 | 5.4 | 10 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.2B USD | 11.4 | -26.8 | -28.9 | -26.2 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.3B USD | 0.8 | 13.8 | 7.3 | 9.8 |